Effects of prolonged post-fixation on vascular biomarkers in postmortem human brains

This study demonstrates that prolonged neutral-buffered formalin post-fixation (up to 20 years) differentially affects the staining intensity of specific vascular and cellular biomarkers in postmortem human brains, necessitating standardized fixation times or statistical adjustments when interpreting neuropathological data.

The Gist

The Big Picture: The "Brain Library" Problem

Imagine a massive library where scientists keep preserved human brains to study diseases like Alzheimer's and stroke. These brains are like rare, ancient books. To keep them from rotting, they are soaked in a special preservative fluid (formalin) for a long time—sometimes for just a year, but often for 10, 15, or even 20 years.

The problem? Scientists aren't sure if soaking these "books" in preservative for two decades changes the "ink" (the biological markers) inside them. If the ink fades or changes color over time, scientists might misread the story, thinking a disease is present when it isn't, or missing it entirely.

This study asked a simple question: Does the length of time a brain sits in preservative fluid ruin our ability to see specific disease markers?

The Experiment: Testing the "Ink"

The researchers took brain samples from the prefrontal cortex (the part of the brain behind your forehead) that had been preserved for 1, 5, 10, 15, and 20 years. They treated these samples like a science fair project, testing them with two different methods:

1. Immunohistochemistry (IHC): Think of this as using magnetic stickers. Scientists use special antibodies (the magnets) that stick only to specific proteins (the metal) in the brain. If the protein is there, the sticker sticks and glows.
2. Histochemistry (HC): Think of this as using colored dyes. These dyes stain specific parts of the tissue (like blood vessels or nerve fibers) so they stand out against the background.

They tested 8 different "targets" (6 proteins and 2 dye patterns) that are crucial for understanding brain health, blood flow, and inflammation.

The Results: Some Ink Fades, Some Doesn't

The study found that the preservative fluid didn't treat all the "ink" the same way. It was a mixed bag:

📉 The "Fading Ink" (Bad News for Long-Term Storage)

Some markers got significantly weaker or disappeared completely the longer the brain sat in the jar.

• Ferritin (Iron): Imagine trying to find a rust spot on an old car. The longer the car sits in the rain, the harder it is to see the rust because the chemical reaction fades. The longer the brain was fixed, the harder it was to see iron deposits.
• Vimentin (The Skeleton): This marks the "scaffolding" of cells. In brains fixed for 20 years, this marker was almost completely gone. It's like the scaffolding in a building slowly dissolving until the structure looks empty.
• Collagen-IV (The Pipes): This marks the walls of blood vessels. Over time, the "paint" on these pipes started to peel off, making them hard to see.
• Bielschowsky Silver Stain (The Nerve Fibers): This dye highlights nerve fibers. In the oldest samples (20 years), the dye didn't stick as well, making the fibers look faint.

🛡️ The "Stain-Proof Ink" (Good News!)

Some markers were incredibly tough. No matter if the brain was 1 year old or 20 years old, these markers stayed bright and clear.

• Claudin-5 (The Gatekeeper): This protein seals the gaps between blood vessels (the Blood-Brain Barrier). It was rock solid, even after 20 years.
• PLP (The Insulation): This marks the insulation around nerves. It stayed consistent, suggesting it's a reliable marker even in very old samples.
• Masson's Trichrome (The General Dye): This dye, used to see general tissue structure, didn't change much over time.

The "CD68" Mystery: The Faint Whisper

There was one marker for inflammation (CD68) that showed a trend of fading, but the change wasn't statistically loud enough to be 100% certain. However, the researchers suspect it might be fading slightly, just like a whisper getting quieter over time.

The Takeaway: How to Read the Library Books

The main lesson from this paper is that time matters.

If you are a scientist looking at a brain sample from a brain bank:

1. Don't mix your groups: You can't compare a brain fixed for 1 year with one fixed for 20 years and expect the results to be fair. It's like comparing a fresh photo to a faded Polaroid; the colors won't match.
2. Check the "Date Stamped": You must know how long the brain was in the preservative. If you are studying iron or blood vessel walls, you need to account for the fact that these markers might look weaker just because of time, not because the disease is worse.
3. Pick the right tool: If you are studying a brain that has been sitting for decades, avoid using markers like Ferritin or Vimentin, as they might be too faded to trust. Stick to the "stain-proof" ones like Claudin-5.

The Bottom Line

Preserving brains is a miracle that allows us to study diseases, but the preservative fluid is a double-edged sword. It stops the brain from rotting, but it slowly changes the chemical "ink" inside. To get the story right, scientists need to know exactly how long the brain has been in the jar and choose their tools carefully so they don't misread the history of the disease.

Technical Summary

1. Problem Statement

Postmortem human brains stored in brain banks are critical resources for studying neurodegenerative diseases (NDDs) and cerebrovascular diseases (CVD). However, these tissues are often preserved in neutral-buffered formalin (NBF) for extended periods—ranging from months to decades—before analysis. While NBF preserves tissue integrity, it induces protein and nucleic acid crosslinking, which can mask antigenic epitopes and alter immunoreactivity.

Although previous studies have noted that prolonged fixation affects certain markers (e.g., NeuN, Iba1), there is a lack of systematic data regarding how fixation duration impacts specific biomarkers used for CVD and NDD research, particularly those related to the blood-brain barrier (BBB), microvasculature, and iron accumulation. This uncertainty complicates the interpretation of histological data from brain banks, where samples with varying fixation histories are often compared.

2. Methodology

Study Design:
The study utilized a cross-sectional design comparing human prefrontal cortex (PFC) specimens fixed for 1, 5, 10, 15, and 20 years.

• Sample Size: 20 specimens total (4 per fixation group).
• Source: Douglas Brain Bank (Quebec, Canada).
• Demographics: Groups varied in age and diagnosis. Notably, the 10-year group consisted of older individuals with confirmed CVD/NDD diagnoses (Alzheimer's, Lewy Body, etc.), while other groups were primarily normal aging. Postmortem intervals (PMI) were not significantly different across groups.

Tissue Processing:

• Fixation: All samples were fixed in 10% NBF.
• Sectioning:
  • Immunohistochemistry (IHC): 50-µm free-floating sections.
  • Histochemistry (HC): 20-µm mounted sections.
• Antigen Retrieval: All IHC sections underwent heat-induced antigen retrieval (105°C, sodium citrate buffer, pH 6.0) to mitigate crosslinking effects.

Biomarkers Analyzed:

• IHC Targets (6 markers):
  • BBB/Microvasculature: Collagen-IV, Claudin-5, Vimentin.
  • Neuroinflammation: CD68 (activated microglia).
  • Myelin: Proteolipid Protein (PLP).
  • Iron: Ferritin.
• Histochemistry (2 stains):
  • Masson's Trichrome Stain (MTS).
  • Bielschowsky Silver Stain (BSS).

Quantification & Statistics:

• Imaging: 10 brightfield images (20X) per specimen were captured in both Gray Matter (GM) and White Matter (WM).
• Analysis: Staining intensity was quantified using ImageJ (threshold-based) and MATLAB (RGB values).
• Statistical Model: Linear mixed-effect models were used to compare fixation groups against the 1-year reference group, adjusting for age, sex, and PMI. Results were corrected for multiple comparisons using the False Discovery Rate (FDR).

3. Key Results

The study revealed differential effects of prolonged fixation depending on the specific biomarker:

A. Markers Significantly Affected by Prolonged Fixation (Decreased Intensity):

• Ferritin: Showed a significant decline in staining intensity in both GM and WM as fixation time increased (15 and 20 years showed the most drastic drops).
• Vimentin: Intensity decreased significantly in GM and WM, with staining becoming completely absent in the 20-year group.
• Collagen-IV: Significant reduction in GM and WM, particularly in the 15 and 20-year groups.
• Bielschowsky Silver Stain (BSS): Significant reduction in GM intensity in the 20-year group compared to the 1-year group.

B. Markers Remaining Stable (No Significant Change):

• CD68 (Activated Microglia): Showed a non-significant downward trend but remained detectable across all groups.
• PLP (Myelin): No significant changes in GM or WM intensity, suggesting it is more robust than Luxol Fast Blue (a stain previously found to degrade with fixation).
• Claudin-5 (BBB Tight Junctions): Staining intensity remained stable across all fixation durations.
• Masson's Trichrome Stain (MTS): No significant differences in intensity across groups, indicating robustness for collagen/fibrin detection.

C. Specific Observations:

• The 10-year group (diagnosed with pathology) showed higher variability in CD68 and Claudin-5, likely due to underlying disease pathology (neuroinflammation and BBB disruption) rather than fixation effects alone.
• In the 20-year group, Vimentin staining was entirely lost, indicating a threshold where antigen retrieval is insufficient to recover the epitope.

4. Key Contributions

1. Biomarker-Specific Stability Profiles: The study provides a definitive guide on which vascular and neurodegenerative markers are robust to decades of formalin fixation and which are not.
   • Robust: Claudin-5, PLP, MTS.
   • Vulnerable: Ferritin, Vimentin, Collagen-IV, BSS.
2. Quantitative Evidence: Unlike previous qualitative studies, this research offers quantitative data (mixed-effect models) demonstrating the statistical significance of fixation-induced signal loss.
3. Methodological Recommendations: The authors establish that antigen retrieval protocols, while standard, cannot fully reverse the degradation of certain epitopes (like Ferritin and Vimentin) after extreme fixation times.

5. Significance and Implications

• Interpretation of Brain Bank Data: Researchers utilizing postmortem brains must account for fixation duration. Comparing a 1-year fixed sample to a 20-year fixed sample without adjustment could lead to false negatives (e.g., underestimating iron accumulation or vascular damage).
• Experimental Design:
  • Covariate Adjustment: Post-fixation duration should be included as a covariate in statistical analyses of neuropathological data.
  • Matching: Studies should ideally compare specimens with similar fixation times.
  • Marker Selection: For long-term fixed tissues, researchers should prioritize stable markers (e.g., Claudin-5, PLP) over vulnerable ones (e.g., Ferritin, Vimentin) or adjust protocols accordingly.
• Clinical Relevance: Since CVD and NDDs are often studied using archived brain banks, these findings ensure that conclusions regarding vascular integrity, iron deposition, and myelin loss are not artifacts of tissue preservation time.

In conclusion, the paper underscores that while NBF fixation is essential for tissue preservation, it introduces variable biases across different biomarkers. Accurate neuropathological assessment requires acknowledging these differential effects to avoid misinterpretation of disease mechanisms.